Vanguard Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $9.8B | Buy |
35,895,583
+588,509
| +2% | +$160M | 0.14% | 114 |
|
|
2025
Q3 | $9.54B | Buy |
35,307,074
+130,698
| +0.4% | +$35.6M | 0.14% | 117 |
|
|
2025
Q2 | $9.7B | Buy |
35,176,376
+532,549
| +2% | +$145M | 0.16% | 112 |
|
|
2025
Q1 | $9.19B | Buy |
34,643,827
+400,737
| +1% | +$98.9M | 0.17% | 108 |
|
|
2024
Q4 | $7.95B | Buy |
34,243,090
+326,623
| +1% | +$75.1M | 0.14% | 114 |
|
|
2024
Q3 | $7.48B | Buy |
33,916,467
+347,333
| +1% | +$71.9M | 0.13% | 129 |
|
|
2024
Q2 | $6.6B | Buy |
33,569,134
+165,762
| +0.5% | +$34.2M | 0.13% | 133 |
|
|
2024
Q1 | $7.19B | Sell |
33,403,372
-47,822
| -0.1% | -$10M | 0.14% | 124 |
|
|
2023
Q4 | $7.04B | Buy |
33,451,194
+215,044
| +0.6% | +$45.9M | 0.15% | 110 |
|
|
2023
Q3 | $6.65B | Sell |
33,236,150
-73,442
| -0.2% | -$14.6M | 0.16% | 106 |
|
|
2023
Q2 | $6.17B | Buy |
33,309,592
+24,748
| +0.1% | +$4.57M | 0.15% | 119 |
|
|
2023
Q1 | $6.37B | Buy |
33,284,844
+145,666
| +0.4% | +$26.3M | 0.16% | 107 |
|
|
2022
Q4 | $5.57B | Buy |
33,139,178
+371,668
| +1% | +$64.6M | 0.15% | 122 |
|
|
2022
Q3 | $5.8B | Buy |
32,767,510
+429,912
| +1% | +$85M | 0.17% | 102 |
|
|
2022
Q2 | $6.62B | Buy |
32,337,598
+489,748
| +2% | +$104M | 0.19% | 89 |
|
|
2022
Q1 | $7.58B | Buy |
31,847,850
+490,885
| +2% | +$115M | 0.18% | 93 |
|
|
2021
Q4 | $7.16B | Buy |
31,356,965
+254,162
| +0.8% | +$55.9M | 0.16% | 104 |
|
|
2021
Q3 | $6.01B | Buy |
31,102,803
+219,691
| +0.7% | +$44.5M | 0.15% | 109 |
|
|
2021
Q2 | $6.57B | Buy |
30,883,112
+275,279
| +0.9% | +$58.1M | 0.16% | 101 |
|
|
2021
Q1 | $6.25B | Buy |
30,607,833
+2,376,218
| +8% | +$468M | 0.17% | 98 |
|
|
2020
Q4 | $5.14B | Sell |
28,231,615
-370,502
| -1% | -$63M | 0.15% | 116 |
|
|
2020
Q3 | $4.79B | Sell |
28,602,117
-514,223
| -2% | -$86.6M | 0.16% | 111 |
|
|
2020
Q2 | $4.73B | Sell |
29,116,340
-252,801
| -0.9% | -$45.3M | 0.17% | 105 |
|
|
2020
Q1 | $5.08B | Buy |
29,369,141
+747,528
| +3% | +$149M | 0.22% | 87 |
|
|
2019
Q4 | $5.74B | Buy |
28,621,613
+383,480
| +1% | +$78.7M | 0.2% | 92 |
|
|
2019
Q3 | $5.97B | Buy |
28,238,133
+245,676
| +0.9% | +$51.3M | 0.22% | 82 |
|
|
2019
Q2 | $5.43B | Buy |
27,992,457
+328,318
| +1% | +$60.5M | 0.2% | 86 |
|
|
2019
Q1 | $4.55B | Buy |
27,664,139
+392,627
| +1% | +$69.4M | 0.18% | 98 |
|
|
2018
Q4 | $5.13B | Buy |
27,271,512
+1,957,999
| +8% | +$362M | 0.23% | 77 |
|
|
2018
Q3 | $4.31B | Buy |
25,313,513
+47,617
| +0.2% | +$8.02M | 0.17% | 108 |
|
|
2018
Q2 | $4.14B | Buy |
25,265,896
+411,507
| +2% | +$67.2M | 0.17% | 105 |
|
|
2018
Q1 | $4.02B | Buy |
24,854,389
+763,407
| +3% | +$122M | 0.18% | 105 |
|
|
2017
Q4 | $3.52B | Buy |
24,090,982
+368,439
| +2% | +$52.5M | 0.15% | 121 |
|
|
2017
Q3 | $3.22B | Buy |
23,722,543
+926,649
| +4% | +$117M | 0.15% | 126 |
|
|
2017
Q2 | $2.85B | Buy |
22,795,894
+563,460
| +3% | +$67.4M | 0.14% | 131 |
|
|
2017
Q1 | $2.64B | Buy |
22,232,434
+806,282
| +4% | +$97M | 0.14% | 136 |
|
|
2016
Q4 | $2.47B | Buy |
21,426,152
+618,829
| +3% | +$68.9M | 0.14% | 138 |
|
|
2016
Q3 | $2.17B | Buy |
20,807,323
+675,566
| +3% | +$70.5M | 0.13% | 156 |
|
|
2016
Q2 | $1.96B | Buy |
20,131,757
+406,686
| +2% | +$38.4M | 0.12% | 165 |
|
|
2016
Q1 | $1.89B | Buy |
19,725,071
+699,344
| +4% | +$63.6M | 0.12% | 159 |
|
|
2015
Q4 | $1.72B | Buy |
19,025,727
+561,735
| +3% | +$52.9M | 0.12% | 168 |
|
|
2015
Q3 | $1.71B | Buy |
18,463,992
+776,416
| +4% | +$73.8M | 0.12% | 159 |
|
|
2015
Q2 | $1.65B | Buy |
17,687,576
+62,443
| +0.4% | +$5.83M | 0.11% | 181 |
|
|
2015
Q1 | $1.67B | Buy |
17,625,133
+867,778
| +5% | +$80.4M | 0.11% | 183 |
|
|
2014
Q4 | $1.49B | Buy |
16,757,355
+605,216
| +4% | +$51.3M | 0.11% | 193 |
|
|
2014
Q3 | $1.29B | Buy |
16,152,139
+360,642
| +2% | +$27.2M | 0.1% | 212 |
|
|
2014
Q2 | $1.12B | Buy |
15,791,497
+359,393
| +2% | +$25.3M | 0.09% | 235 |
|
|
2014
Q1 | $1.14B | Buy |
15,432,104
+357,082
| +2% | +$26.9M | 0.1% | 220 |
|
|
2013
Q4 | $1.18B | Buy |
15,075,022
+256,538
| +2% | +$20.1M | 0.1% | 193 |
|
|
2013
Q3 | $1.09B | Buy |
14,818,484
+458,163
| +3% | +$33.8M | 0.11% | 185 |
|
|
2013
Q2 | $1.09B | Buy |
+14,360,321
| New | +$942M | 0.11% | 163 |
|
Other funds holding CME
Vanguard Group's CME Position: Q4 2025 in Review
Vanguard Group increased its CME Group (CME) stake by 1.7% in Q4 2025, buying an estimated $160M and bringing the position to 35,895,583 shares worth $9.8B. The position accounts for 0.14% of the portfolio, ranked #114.
Vanguard Group first reported a position in CME in Q2 2013 and has held it in 51 quarters since. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.
- Vanguard Group held 35,895,583 shares of CME Group worth $9.8B as of Q4 2025.
- Vanguard Group bought 588,509 CME Group shares in Q4 2025, an estimated $160M.
- CME Group made up 0.14% of Vanguard Group's portfolio in Q4 2025, its #114 holding.
- Vanguard Group first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
- 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.